Response of Patients on Surveillance for Prostate Cancer to Dutasteride
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Hypothesis: That, in men on surveillance for favorable risk prostate cancer treated with
dutasteride, prostate specific antigen (PSA) kinetics is of value in identifying those men
who harbor occult high grade prostate cancer.
The study will determine the prevalence of a secondary rise in PSA > 0.5 ng/ml and the PSA
doubling time in subjects on surveillance being treated with dutasteride.